1143 POSTER Oral palonosetron (PALO) is as effective as intravenous (IV) PALO: a phase 3 dose ranging trial in patients (pts) receiving moderately emetogenic chemotherapy (MEC)
S. Grunberg, D. Voisin, M. Zufferli, G. PiracciniТом:
5
Рік:
2007
Мова:
english
DOI:
10.1016/s1359-6349(07)70662-6
Файл:
PDF, 61 KB
english, 2007